Xeris Biopharma Holdings, Inc. Common Stock

XERS US98422E1038

💰
Capitalization
Small-cap

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

🔗
Website
https://www.xerispharma.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
17
🙍
Insiders
9
Person Price Shares Total Published Completed
Persky Marla
 7.72
USD 		15,500
Sold 		119,610
USD 		11/09/2025 11/09/2025
Sherman Jeffrey W
 7.92
USD 		42,232
Sold 		334,515
USD 		28/08/2025 28/08/2025
Johnson John
 7.32
USD 		107,500
Sold 		786,459
USD 		13/08/2025 13/08/2025
Halkuff Dawn
 7.28
USD 		42,500
Sold 		309,226
USD 		12/08/2025 12/08/2025
Mcculloch Kevin
O 		4.38
USD 		25,000
Bought 		109,475
USD 		13/06/2025 13/06/2025
Mcculloch Kevin
O 		4.38
USD 		25,000
Bought 		109,475
USD 		13/06/2025 13/06/2025
Hecht Beth
O 		5.43
USD 		40,000
Sold 		217,244
USD 		20/03/2025 20/03/2025
Schmid John P.
 2.25
USD 		4,515
Bought 		10,147
USD 		12/08/2024 12/08/2024
Schmid John P.
 2.37
USD 		4,285
Bought 		10,134
USD 		09/08/2024 09/08/2024
Schmid John P.
 1.91
USD 		5,400
Bought 		10,314
USD 		10/05/2024 10/05/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Xeris Biopharma Holdings, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Johnson John 1 786,459.25 786,459.25 13/08/2025 13/08/2025
Sherman Jeffrey W 2 344,613.45 172,306.73 27/11/2023 28/08/2025
Halkuff Dawn 2 319,180.15 159,590.08 20/11/2023 12/08/2025
Mcculloch Kevin 2 218,950.00 109,475.00 13/06/2025 13/06/2025
Hecht Beth 1 217,244.00 217,244.00 20/03/2025 20/03/2025
Persky Marla 2 129,667.99 64,834.00 14/11/2023 11/09/2025
Pieper Steven 1 54,600.00 54,600.00 20/11/2023 20/11/2023
Shannon John Patrick Jr 1 50,399.62 50,399.62 17/11/2023 17/11/2023
Schmid John P. 5 50,130.04 10,026.01 16/11/2023 12/08/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.